Watson-Andrx Merger Deadline Extended
This article was originally published in The Pink Sheet Daily
Executive Summary
The closing date for the Watson-Andrx merger is being extended from Sept. 12 to Nov. 13 to allow for "additional time to confer with the FTC," the companies announced July 10
You may also be interested in...
Generic Pravachol Leads Watson To Strong 2Q Sales
Company also anticipates three generic launches in the second half of the year.
Generic Pravachol Leads Watson To Strong 2Q Sales
Company also anticipates three generic launches in the second half of the year.
Teva Will Inherit OAI Status Of Andrx' Oral Contraceptives
FDA will continue to block approval of Andrx' oral contraceptives until manufacturing issues are resolved despite the company's intention to transfer its pending ANDAs to Teva